Trimethobenzamide Hydrochloride
3 NDCs across 2 manufacturers|3 Generic,0 Brand
Trimethobenzamide Hydrochloride is used to treat nausea and vomiting, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Oct 19, 1982. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient.
Trimethobenzamide Hydrochloride is available as 3 NDCs from 2 manufacturers (3 generic, 0 brand), with NADAC prices from $1.29 to $18.00 per EA — the most expensive product costs about 14× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
2
competing in market
Price Spread
$1.29 – $18.00
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Lupin Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antiemetic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing TRIMETHOBENZAMIDE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRIMETHOBENZAMIDE 300 MG CAP | $17.9997 per EA | — |
TRIMETHOBENZAMIDE 300 MG CAP | $1.2941 per EA | — |
TRIMETHOBENZAMIDE 300 MG CAP | $1.2941 per EA | — |
Frequently Asked Questions
What is Trimethobenzamide Hydrochloride used to treat?
Trimethobenzamide Hydrochloride is used to treat nausea and vomiting, per the National Library of Medicine's MED-RT classification.
When did Trimethobenzamide Hydrochloride become available as a generic?
FDA approved the first generic Trimethobenzamide Hydrochloride (ANDA) on Oct 19, 1982. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Trimethobenzamide Hydrochloride products are on the market?
The Trimethobenzamide Hydrochloride drug market contains 3 NDCs from 2 manufacturers — 3 generic and 0 brand products.
What is the price range for Trimethobenzamide Hydrochloride?
NADAC reference prices for Trimethobenzamide Hydrochloride range from $1.2941 to $17.9997 per EA — the most expensive product costs about 14× the cheapest.
Which manufacturers make Trimethobenzamide Hydrochloride?
2 manufacturers list Trimethobenzamide Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Lupin Pharmaceuticals Inc. (2), Chartwell RX LLC (1).